 Connection
Vikhyat Bebarta to Hydroxocobalamin
This is a "connection" page, showing publications Vikhyat Bebarta has written about Hydroxocobalamin.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
7.190 |
|
|
|
-
Maddry JK, Paredes RM, Rebeles J, Olson G, Castaneda M, Canellis K, Ng PC, Bebarta VS. Efficacy of Intravenous Hydroxocobalamin for Treatment of Sodium Methanethiolate Exposure in a Swine Model (Sus scrofa) of Severe Methanethiol Toxicity. J Med Toxicol. 2020 10; 16(4):388-397.
Score: 0.684
-
Bebarta VS, Garrett N, Maddry JK, Arana A, Boudreau S, Castaneda M, Dixon P, Tanen DA. A prospective, randomized trial of intravenous hydroxocobalamin versus noradrenaline or saline for treatment of lipopolysaccharide-induced hypotension in a swine model. Clin Exp Pharmacol Physiol. 2019 03; 46(3):216-225.
Score: 0.635
-
Bebarta VS, Garrett N, Boudreau S, Castaneda M. Intravenous Hydroxocobalamin Versus Hextend Versus Control for Class III Hemorrhage Resuscitation in a Prehospital Swine Model. Mil Med. 2018 11 05; 183(11-12):e721-e729.
Score: 0.621
-
Bebarta VS, Garrett N, Brenner M, Mahon SB, Maddry JK, Boudreau S, Castaneda M, Boss GR. Efficacy of Intravenous Cobinamide Versus Hydroxocobalamin or Saline for Treatment of Severe Hydrogen Sulfide Toxicity in a Swine (Sus scrofa) Model. Acad Emerg Med. 2017 09; 24(9):1088-1098.
Score: 0.570
-
Bebarta VS, Garrett N, Boudreau S, Castaneda M. A prospective, randomized trial of intravenous hydroxocobalamin versus whole blood transfusion compared to no treatment for Class III hemorrhagic shock resuscitation in a prehospital swine model. Acad Emerg Med. 2015 Mar; 22(3):321-30.
Score: 0.481
-
Bebarta VS, Tanen DA, Boudreau S, Castaneda M, Zarzabal LA, Vargas T, Boss GR. In reply. Ann Emerg Med. 2015 Feb; 65(2):235.
Score: 0.478
-
Bebarta VS, Garrett N, Boudreau S, Castaneda M. Intraosseous hydroxocobalamin versus intravenous hydroxocobalamin compared to intraosseous whole blood or no treatment for hemorrhagic shock in a swine model. Am J Disaster Med. 2015; 10(3):205-15.
Score: 0.476
-
Bebarta VS, Pitotti RL, Boudreau S, Tanen DA. Intraosseous versus intravenous infusion of hydroxocobalamin for the treatment of acute severe cyanide toxicity in a Swine model. Acad Emerg Med. 2014 Nov; 21(11):1203-11.
Score: 0.470
-
Bebarta VS, Tanen DA, Boudreau S, Castaneda M, Zarzabal LA, Vargas T, Boss GR. Intravenous cobinamide versus hydroxocobalamin for acute treatment of severe cyanide poisoning in a swine (Sus scrofa) model. Ann Emerg Med. 2014 Dec; 64(6):612-9.
Score: 0.453
-
Bebarta VS, Pitotti R, Lairet J, Dixon P, Bush A, Tanen DA. In reply. Ann Emerg Med. 2013 Jan; 61(1):125-6.
Score: 0.414
-
Schwertner HA, Valtier S, Bebarta VS. Liquid chromatographic mass spectrometric (LC/MS/MS) determination of plasma hydroxocobalamin and cyanocobalamin concentrations after hydroxocobalamin antidote treatment for cyanide poisoning. J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Sep 15; 905:10-6.
Score: 0.403
-
Bebarta VS, Pitotti RL, Dixon PS, Valtier S, Esquivel L, Bush A, Little CM. Hydroxocobalamin and epinephrine both improve survival in a swine model of cyanide-induced cardiac arrest. Ann Emerg Med. 2012 Oct; 60(4):415-22.
Score: 0.392
-
Bebarta VS, Pitotti RL, Dixon P, Lairet JR, Bush A, Tanen DA. Hydroxocobalamin versus sodium thiosulfate for the treatment of acute cyanide toxicity in a swine (Sus scrofa) model. Ann Emerg Med. 2012 Jun; 59(6):532-9.
Score: 0.391
-
Bebarta VS, Tanen DA, Lairet J, Dixon PS, Valtier S, Bush A. Hydroxocobalamin and sodium thiosulfate versus sodium nitrite and sodium thiosulfate in the treatment of acute cyanide toxicity in a swine (Sus scrofa) model. Ann Emerg Med. 2010 Apr; 55(4):345-51.
Score: 0.334
-
Jiwani AZ, Bebarta VS, Cancio LC. Acquired methemoglobinemia after hydroxocobalamin administration in a patient with burns and inhalation injury. Clin Toxicol (Phila). 2018 05; 56(5):370-372.
Score: 0.144
-
Hamad E, Babu K, Bebarta VS. Case Files of the University of Massachusetts Toxicology Fellowship: Does This Smoke Inhalation Victim Require Treatment with Cyanide Antidote? J Med Toxicol. 2016 06; 12(2):192-8.
Score: 0.131
-
Streitz MJ, Bebarta VS, Borys DJ, Morgan DL. Patterns of cyanide antidote use since regulatory approval of hydroxocobalamin in the United States. Am J Ther. 2014 Jul-Aug; 21(4):244-9.
Score: 0.115
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|